TSE:268AElectronic
Assessing Rigaku Holdings (TSE:268A) Valuation After New Indomethacin Polymorph Research Publication
Rigaku Holdings (TSE:268A) drew fresh attention after its group company, Rigaku Corporation, reported the publication of joint research on a newly discovered polymorph of indomethacin in the journal Crystal Growth & Design.
See our latest analysis for Rigaku Holdings.
The joint research news lands after a volatile stretch for the stock, with a 1-day share price return of 6.2% partially offsetting a 7-day share price decline of 18.02%. The 1-year total shareholder return of 270.5% points to...